FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals North America Seconal Sodium Recall

SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Jul 6, 2016
Recall ID
D-1059-2016
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Seconal Sodium starting Jun 10, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1059-2016 on Jul 6, 2016. Reason: Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.

Product description

SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only. Distributed by: Valeant Pharmaceuticals North America, LLC, Bridgewater, NJ 08807. NDC: 0187-4220-10.

Lot numbers, UPCs & expiration codes

Lot #: 2555979, Expiry: 09/2016.

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1059-2016
Classification
Class III
Status
Terminated
Recall initiated
Jun 10, 2016
FDA report date
Jul 6, 2016
Quantity
958 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-1059-2016, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
74532
Address
400 Somerset Corporate Blvd
Code information
Lot #: 2555979, Expiry: 09/2016.
Postal code
08807-2867
Report date
Jul 6, 2016
Product type
Drugs
Recall number
D-1059-2016
Classification
Class III
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
958 Bottles
Termination date
Jun 14, 2017
Reason for recall
Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.
Voluntary / mandated
Voluntary: Firm initiated
Product description
SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only. Distributed by: Valeant Pharmaceuticals North America, LLC, Bridgewater, NJ 08807. NDC: 0187-4220-10.
Distribution pattern
US Nationwide
Recall initiation date
Jun 10, 2016
Initial firm notification
Letter
Center classification date
Jun 30, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1059-2016, published Jul 6, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls